Industry Research Reports

Home > Reports > Service & Software > Global AI-based Clinical Trial Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global AI-based Clinical Trial Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Service & Software

Published Date: 2025-02-20

Pages: 95 Pages

Report ld: 4026924

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global AI-based Clinical Trial Solution market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.

AI is being used to enhance patient recruitment and retention in clinical trials. Predictive analytics and machine learning algorithms help identify eligible participants more efficiently, and personalized engagement strategies improve patient retention.

The global AI-based Clinical Trial Solution market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global AI-based Clinical Trial Solution market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

AiCure
Antidote
Deep Lens
Saama Technologies
Trials.ai
Deep 6 AI
Innoplexus
Median Technologies
Mendel.ai
Phesi
Deloitte
Innoplexus
IBM

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Artificial Narrow Intelligence
Artificial General Intelligence
Artificial Super Intelligence

Segment by Application

Drug Discovery
Drug Manufacturing
Drug Marketing
Diagnosis and Treatment
Clinical Trials

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Revenue of AI-based Clinical Trial Solution in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of AI-based Clinical Trial Solution manufacturers competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by Type, by Application, revenue for each segment.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AI-based Clinical Trial Solution revenue, gross margin, and recent development, etc.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Report Overview

1.1 Study Scope

1.2 Market by Type

1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031

1.2.2 Artificial Narrow Intelligence

1.2.3 Artificial General Intelligence

1.2.4 Artificial Super Intelligence

1.3 Market by Application

1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031

1.3.2 Drug Discovery

1.3.3 Drug Manufacturing

1.3.4 Drug Marketing

1.3.5 Diagnosis and Treatment

1.3.6 Clinical Trials

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global AI-based Clinical Trial Solution Market Perspective (2020-2031)

2.2 Global Market Size by Region: 2020 VS 2024 VS 2031

2.3 Global AI-based Clinical Trial Solution Revenue Market Share by Region (2020-2025)

2.4 Global AI-based Clinical Trial Solution Revenue Forecast by Region (2026-2031)

2.5 Major Region and Emerging Market Analysis

2.5.1 North America AI-based Clinical Trial Solution Market Size and Prospective (2020-2031)

2.5.2 Europe AI-based Clinical Trial Solution Market Size and Prospective (2020-2031)

2.5.3 Asia-Pacific AI-based Clinical Trial Solution Market Size and Prospective (2020-2031)

3 Breakdown Data by Type

3.1 Global AI-based Clinical Trial Solution Historic Market Size by Type (2020-2025)

3.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Type (2026-2031)

3.3 Different Types AI-based Clinical Trial Solution Representative Players

4 Breakdown Data by Application

4.1 Global AI-based Clinical Trial Solution Historic Market Size by Application (2020-2025)

4.2 Global AI-based Clinical Trial Solution Forecasted Market Size by Application (2026-2031)

4.3 New Sources of Growth in AI-based Clinical Trial Solution Application

5 Competition Landscape by Players

5.1 Global Top Players by Revenue

5.1.1 Global Top AI-based Clinical Trial Solution Players by Revenue (2020-2025)

5.1.2 Global AI-based Clinical Trial Solution Revenue Market Share by Players (2020-2025)

5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

5.3 Players Covered: Ranking by AI-based Clinical Trial Solution Revenue

5.4 Global AI-based Clinical Trial Solution Market Concentration Analysis

5.4.1 Global AI-based Clinical Trial Solution Market Concentration Ratio (CR5 and HHI)

5.4.2 Global Top 10 and Top 5 Companies by AI-based Clinical Trial Solution Revenue in 2024

5.5 Global Key Players of AI-based Clinical Trial Solution Head office and Area Served

5.6 Global Key Players of AI-based Clinical Trial Solution, Product and Application

5.7 Global Key Players of AI-based Clinical Trial Solution, Date of Enter into This Industry

5.8 Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments and Downstream

6.1.1 North America AI-based Clinical Trial Solution Revenue by Company (2020-2025)

6.1.2 North America Market Size by Type

6.1.2.1 North America AI-based Clinical Trial Solution Market Size by Type (2020-2025)

6.1.2.2 North America AI-based Clinical Trial Solution Market Share by Type (2020-2025)

6.1.3 North America Market Size by Application

6.1.3.1 North America AI-based Clinical Trial Solution Market Size by Application (2020-2025)

6.1.3.2 North America AI-based Clinical Trial Solution Market Share by Application (2020-2025)

6.1.4 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments and Downstream

6.2.1 Europe AI-based Clinical Trial Solution Revenue by Company (2020-2025)

6.2.2 Europe Market Size by Type

6.2.2.1 Europe AI-based Clinical Trial Solution Market Size by Type (2020-2025)

6.2.2.2 Europe AI-based Clinical Trial Solution Market Share by Type (2020-2025)

6.2.3 Europe Market Size by Application

6.2.3.1 Europe AI-based Clinical Trial Solution Market Size by Application (2020-2025)

6.2.3.2 Europe AI-based Clinical Trial Solution Market Share by Application (2020-2025)

6.2.4 Europe Market Trend and Opportunities

6.3 Asia-Pacific Market: Players, Segments and Downstream

6.3.1 Asia-Pacific AI-based Clinical Trial Solution Revenue by Company (2020-2025)

6.3.2 Asia-Pacific Market Size by Type

6.3.2.1 Asia-Pacific AI-based Clinical Trial Solution Market Size by Type (2020-2025)

6.3.2.2 Asia-Pacific AI-based Clinical Trial Solution Market Share by Type (2020-2025)

6.3.3 Asia-Pacific Market Size by Application

6.3.3.1 Asia-Pacific AI-based Clinical Trial Solution Market Size by Application (2020-2025)

6.3.3.2 Asia-Pacific AI-based Clinical Trial Solution Market Share by Application (2020-2025)

6.3.4 Asia-Pacific Market Trend and Opportunities

7 Key Players Profiles

7.1 AiCure

7.1.1 AiCure Company Details

7.1.2 AiCure Business Overview

7.1.3 AiCure AI-based Clinical Trial Solution Introduction

7.1.4 AiCure Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.1.5 AiCure Recent Development

7.2 Antidote

7.2.1 Antidote Company Details

7.2.2 Antidote Business Overview

7.2.3 Antidote AI-based Clinical Trial Solution Introduction

7.2.4 Antidote Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.2.5 Antidote Recent Development

7.3 Deep Lens

7.3.1 Deep Lens Company Details

7.3.2 Deep Lens Business Overview

7.3.3 Deep Lens AI-based Clinical Trial Solution Introduction

7.3.4 Deep Lens Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.3.5 Deep Lens Recent Development

7.4 Saama Technologies

7.4.1 Saama Technologies Company Details

7.4.2 Saama Technologies Business Overview

7.4.3 Saama Technologies AI-based Clinical Trial Solution Introduction

7.4.4 Saama Technologies Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.4.5 Saama Technologies Recent Development

7.5 Trials.ai

7.5.1 Trials.ai Company Details

7.5.2 Trials.ai Business Overview

7.5.3 Trials.ai AI-based Clinical Trial Solution Introduction

7.5.4 Trials.ai Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.5.5 Trials.ai Recent Development

7.6 Deep 6 AI

7.6.1 Deep 6 AI Company Details

7.6.2 Deep 6 AI Business Overview

7.6.3 Deep 6 AI AI-based Clinical Trial Solution Introduction

7.6.4 Deep 6 AI Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.6.5 Deep 6 AI Recent Development

7.7 Innoplexus

7.7.1 Innoplexus Company Details

7.7.2 Innoplexus Business Overview

7.7.3 Innoplexus AI-based Clinical Trial Solution Introduction

7.7.4 Innoplexus Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.7.5 Innoplexus Recent Development

7.8 Median Technologies

7.8.1 Median Technologies Company Details

7.8.2 Median Technologies Business Overview

7.8.3 Median Technologies AI-based Clinical Trial Solution Introduction

7.8.4 Median Technologies Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.8.5 Median Technologies Recent Development

7.9 Mendel.ai

7.9.1 Mendel.ai Company Details

7.9.2 Mendel.ai Business Overview

7.9.3 Mendel.ai AI-based Clinical Trial Solution Introduction

7.9.4 Mendel.ai Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.9.5 Mendel.ai Recent Development

7.10 Phesi

7.10.1 Phesi Company Details

7.10.2 Phesi Business Overview

7.10.3 Phesi AI-based Clinical Trial Solution Introduction

7.10.4 Phesi Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.10.5 Phesi Recent Development

7.11 Deloitte

7.11.1 Deloitte Company Details

7.11.2 Deloitte Business Overview

7.11.3 Deloitte AI-based Clinical Trial Solution Introduction

7.11.4 Deloitte Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.11.5 Deloitte Recent Development

7.12 Innoplexus

7.12.1 Innoplexus Company Details

7.12.2 Innoplexus Business Overview

7.12.3 Innoplexus AI-based Clinical Trial Solution Introduction

7.12.4 Innoplexus Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.12.5 Innoplexus Recent Development

7.13 IBM

7.13.1 IBM Company Details

7.13.2 IBM Business Overview

7.13.3 IBM AI-based Clinical Trial Solution Introduction

7.13.4 IBM Revenue in AI-based Clinical Trial Solution Business (2020-2025)

7.13.5 IBM Recent Development

8 AI-based Clinical Trial Solution Market Dynamics

8.1 AI-based Clinical Trial Solution Industry Trends

8.2 AI-based Clinical Trial Solution Market Drivers

8.3 AI-based Clinical Trial Solution Market Challenges

8.4 AI-based Clinical Trial Solution Market Restraints

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.1.1 Research Programs/Design

10.1.1.2 Market Size Estimation

10.1.1.3 Market Breakdown and Data Triangulation

10.1.2 Data Source

10.1.2.1 Secondary Sources

10.1.2.2 Primary Sources

10.2 Author Details

10.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global AI-based Clinical Trial Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Global AI-based Clinical Trial Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 3. Global Market AI-based Clinical Trial Solution Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global AI-based Clinical Trial Solution Revenue (US$ Million) Market Share by Region (2020-2025)

Table 5. Global AI-based Clinical Trial Solution Revenue Share by Region (2020-2025)

Table 6. Global AI-based Clinical Trial Solution Revenue (US$ Million) Forecast by Region (2026-2031)

Table 7. Global AI-based Clinical Trial Solution Revenue Share Forecast by Region (2026-2031)

Table 8. Global AI-based Clinical Trial Solution Market Size by Type (2020-2025) & (US$ Million)

Table 9. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2020-2025)

Table 10. Global AI-based Clinical Trial Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 11. Global AI-based Clinical Trial Solution Revenue Market Share by Type (2026-2031)

Table 12. Representative Players of Each Type

Table 13. Global AI-based Clinical Trial Solution Market Size by Application (2020-2025) & (US$ Million)

Table 14. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2020-2025)

Table 15. Global AI-based Clinical Trial Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 16. Global AI-based Clinical Trial Solution Revenue Market Share by Application (2026-2031)

Table 17. New Sources of Growth in AI-based Clinical Trial Solution Application

Table 18. Global AI-based Clinical Trial Solution Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global AI-based Clinical Trial Solution Market Share by Players (2020-2025)

Table 20. Global Top AI-based Clinical Trial Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-based Clinical Trial Solution as of 2024)

Table 21. Ranking of Global Top AI-based Clinical Trial Solution Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by AI-based Clinical Trial Solution Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of AI-based Clinical Trial Solution, Headquarters and Area Served

Table 24. Global Key Players of AI-based Clinical Trial Solution, Product and Application

Table 25. Global Key Players of AI-based Clinical Trial Solution, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. North America AI-based Clinical Trial Solution Revenue by Company (2020-2025) & (US$ Million)

Table 28. North America AI-based Clinical Trial Solution Revenue Market Share by Company (2020-2025)

Table 29. North America AI-based Clinical Trial Solution Market Size by Type (2020-2025) & (US$ Million)

Table 30. North America AI-based Clinical Trial Solution Market Size by Application (2020-2025) & (US$ Million)

Table 31. Europe AI-based Clinical Trial Solution Revenue by Company (2020-2025) & (US$ Million)

Table 32. Europe AI-based Clinical Trial Solution Revenue Market Share by Company (2020-2025)

Table 33. Europe AI-based Clinical Trial Solution Market Size by Type (2020-2025) & (US$ Million)

Table 34. Europe AI-based Clinical Trial Solution Market Size by Application (2020-2025) & (US$ Million)

Table 35. Asia-Pacific AI-based Clinical Trial Solution Revenue by Company (2020-2025) & (US$ Million)

Table 36. Asia-Pacific AI-based Clinical Trial Solution Revenue Market Share by Company (2020-2025)

Table 37. Asia-Pacific AI-based Clinical Trial Solution Market Size by Type (2020-2025) & (US$ Million)

Table 38. Asia-Pacific AI-based Clinical Trial Solution Market Size by Application (2020-2025) & (US$ Million)

Table 39. AiCure Company Details

Table 40. AiCure Business Overview

Table 41. AiCure AI-based Clinical Trial Solution Product

Table 42. AiCure Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 43. AiCure Recent Development

Table 44. Antidote Company Details

Table 45. Antidote Business Overview

Table 46. Antidote AI-based Clinical Trial Solution Product

Table 47. Antidote Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 48. Antidote Recent Development

Table 49. Deep Lens Company Details

Table 50. Deep Lens Business Overview

Table 51. Deep Lens AI-based Clinical Trial Solution Product

Table 52. Deep Lens Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 53. Deep Lens Recent Development

Table 54. Saama Technologies Company Details

Table 55. Saama Technologies Business Overview

Table 56. Saama Technologies AI-based Clinical Trial Solution Product

Table 57. Saama Technologies Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 58. Saama Technologies Recent Development

Table 59. Trials.ai Company Details

Table 60. Trials.ai Business Overview

Table 61. Trials.ai AI-based Clinical Trial Solution Product

Table 62. Trials.ai Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 63. Trials.ai Recent Development

Table 64. Deep 6 AI Company Details

Table 65. Deep 6 AI Business Overview

Table 66. Deep 6 AI AI-based Clinical Trial Solution Product

Table 67. Deep 6 AI Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 68. Deep 6 AI Recent Development

Table 69. Innoplexus Company Details

Table 70. Innoplexus Business Overview

Table 71. Innoplexus AI-based Clinical Trial Solution Product

Table 72. Innoplexus Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 73. Innoplexus Recent Development

Table 74. Median Technologies Company Details

Table 75. Median Technologies Business Overview

Table 76. Median Technologies AI-based Clinical Trial Solution Product

Table 77. Median Technologies Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 78. Median Technologies Recent Development

Table 79. Mendel.ai Company Details

Table 80. Mendel.ai Business Overview

Table 81. Mendel.ai AI-based Clinical Trial Solution Product

Table 82. Mendel.ai Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 83. Mendel.ai Recent Development

Table 84. Phesi Company Details

Table 85. Phesi Business Overview

Table 86. Phesi AI-based Clinical Trial Solution Product

Table 87. Phesi Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 88. Phesi Recent Development

Table 89. Deloitte Company Details

Table 90. Deloitte Business Overview

Table 91. Deloitte AI-based Clinical Trial Solution Product

Table 92. Deloitte Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 93. Deloitte Recent Development

Table 94. Innoplexus Company Details

Table 95. Innoplexus Business Overview

Table 96. Innoplexus AI-based Clinical Trial Solution Product

Table 97. Innoplexus Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 98. Innoplexus Recent Development

Table 99. IBM Company Details

Table 100. IBM Business Overview

Table 101. IBM AI-based Clinical Trial Solution Product

Table 102. IBM Revenue in AI-based Clinical Trial Solution Business (2020-2025) & (US$ Million)

Table 103. IBM Recent Development

Table 104. AI-based Clinical Trial Solution Market Trends

Table 105. AI-based Clinical Trial Solution Market Drivers

Table 106. AI-based Clinical Trial Solution Market Challenges

Table 107. AI-based Clinical Trial Solution Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

List of Figures

Figure 1. AI-based Clinical Trial Solution Product Picture

Figure 2. Global AI-based Clinical Trial Solution Market Share by Type: 2024 VS 2031

Figure 3. Artificial Narrow Intelligence Features

Figure 4. Artificial General Intelligence Features

Figure 5. Artificial Super Intelligence Features

Figure 6. Global AI-based Clinical Trial Solution Market Share by Application: 2024 VS 2031

Figure 7. Drug Discovery

Figure 8. Drug Manufacturing

Figure 9. Drug Marketing

Figure 10. Diagnosis and Treatment

Figure 11. Clinical Trials

Figure 12. AI-based Clinical Trial Solution Report Years Considered

Figure 13. Global AI-based Clinical Trial Solution Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global AI-based Clinical Trial Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global AI-based Clinical Trial Solution Revenue Market Share by Region: 2020 VS 2024

Figure 16. North America AI-based Clinical Trial Solution Revenue (US$ Million) Growth Rate (2020-2031)

Figure 17. Europe AI-based Clinical Trial Solution Revenue (US$ Million) Growth Rate (2020-2031)

Figure 18. Asia-Pacific AI-based Clinical Trial Solution Revenue (US$ Million) Growth Rate (2020-2031)

Figure 19. Global AI-based Clinical Trial Solution Market Share by Players in 2024

Figure 20. Global Top AI-based Clinical Trial Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in AI-based Clinical Trial Solution as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by AI-based Clinical Trial Solution Revenue in 2024

Figure 22. North America AI-based Clinical Trial Solution Market Share by Type (2020-2025)

Figure 23. North America AI-based Clinical Trial Solution Market Share by Application (2020-2025)

Figure 24. Europe AI-based Clinical Trial Solution Market Share by Type (2020-2025)

Figure 25. Europe AI-based Clinical Trial Solution Market Share by Application (2020-2025)

Figure 26. Asia-Pacific AI-based Clinical Trial Solution Market Share by Type (2020-2025)

Figure 27. Asia-Pacific AI-based Clinical Trial Solution Market Share by Application (2020-2025)

Figure 28. AiCure Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 29. Antidote Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 30. Deep Lens Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 31. Saama Technologies Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 32. Trials.ai Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 33. Deep 6 AI Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 34. Innoplexus Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 35. Median Technologies Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 36. Mendel.ai Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 37. Phesi Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 38. Deloitte Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 39. Innoplexus Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 40. IBM Revenue Growth Rate in AI-based Clinical Trial Solution Business (2020-2025)

Figure 41. Bottom-up and Top-down Approaches for This Report

Figure 42. Data Triangulation

Figure 43. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global AI-based Clinical Trial Solution market? zhanKai

The top companies in the global AI-based Clinical Trial Solution market are AiCure、Antidote、Deep Lens.

Related Reports

Global AI-based Clinical Trial Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-based Clinical Trial Solution market is projected to grow from US$ 2715 million in 2025 to US$ 13122 million by 2032, at a CAGR of 25.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published Date: 2026-03-09
Pages: 153
USD 4900.00
(Single User License)
Global AI-based Clinical Trial Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-based Clinical Trial Solution market size was US$ 2715 million in 2025 and is forecast to reach a readjusted size of US$ 13122 million by 2032 with a CAGR of 25.2% during the forecast period 2026-2032.
Published Date: 2026-03-09
Pages: 101
USD 4250.00
(Single User License)
AI-based Clinical Trial Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-based Clinical Trial Solution was estimated to be worth US$ 2715 million in 2025 and is projected to reach US$ 13122 million, growing at a CAGR of 25.2% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 135
USD 3950.00
(Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2026
The global AI-based Clinical Trial Solution market was valued at US$ 2715 million in 2025 and is anticipated to reach US$ 13122 million by 2032, at a CAGR of 25.2% from 2026 to 2032.
Published Date: 2026-03-05
Pages: 137
USD 2900.00
(Single User License)
Global AI-based Clinical Trial Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-based Clinical Trial Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published Date: 2025-10-23
Pages: 142
USD 4900.00
(Single User License)
AI-based Clinical Trial Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-based Clinical Trial Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-20
Pages: 117
USD 3950.00
(Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2025
The global market for AI-based Clinical Trial Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-20
Pages: 88
USD 2900.00
(Single User License)
Global AI-based Clinical Trial Solution Market Insights, Forecast to 2030
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published Date: 2024-04-07
Pages: 106
USD 4900.00
(Single User License)
AI-based Clinical Trial Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published Date: 2024-02-19
Pages: 102
USD 3950.00
(Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2024
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published Date: 2024-02-07
Pages: 86
USD 2900.00
(Single User License)

Global AI-based Clinical Trial Solution Market Outlook, In‑Depth Analysis & Forecast to 2032
The global AI-based Clinical Trial Solution market is projected to grow from US$ 2715 million in 2025 to US$ 13122 million by 2032, at a CAGR of 25.2% (2026-2032), driven by critical product segments and diverse end‑use applications.
Published: 2026-03-09
Pages: 153
USD 4900.00 (Single User License)
Global AI-based Clinical Trial Solution Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global AI-based Clinical Trial Solution market size was US$ 2715 million in 2025 and is forecast to reach a readjusted size of US$ 13122 million by 2032 with a CAGR of 25.2% during the forecast period 2026-2032.
Published: 2026-03-09
Pages: 101
USD 4250.00 (Single User License)
AI-based Clinical Trial Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for AI-based Clinical Trial Solution was estimated to be worth US$ 2715 million in 2025 and is projected to reach US$ 13122 million, growing at a CAGR of 25.2% from 2026 to 2032.
Published: 2026-03-05
Pages: 135
USD 3950.00 (Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2026
The global AI-based Clinical Trial Solution market was valued at US$ 2715 million in 2025 and is anticipated to reach US$ 13122 million by 2032, at a CAGR of 25.2% from 2026 to 2032.
Published: 2026-03-05
Pages: 137
USD 2900.00 (Single User License)
Global AI-based Clinical Trial Solution Market Outlook, In‑Depth Analysis & Forecast to 2031
The global AI-based Clinical Trial Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Published: 2025-10-23
Pages: 142
USD 4900.00 (Single User License)
AI-based Clinical Trial Solution- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for AI-based Clinical Trial Solution was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-20
Pages: 117
USD 3950.00 (Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2025
The global market for AI-based Clinical Trial Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-20
Pages: 88
USD 2900.00 (Single User License)
Global AI-based Clinical Trial Solution Market Insights, Forecast to 2030
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published: 2024-04-07
Pages: 106
USD 4900.00 (Single User License)
AI-based Clinical Trial Solution - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published: 2024-02-19
Pages: 102
USD 3950.00 (Single User License)
Global AI-based Clinical Trial Solution Market Research Report 2024
Data integration, evolutionary modelling and pattern recognition using predictive AI models, can enable trial sponsors to aggregate, curate, and analyze large volumes of data, thereby, harnessing information captured during past trials to drive future therapy development initiatives,such as concerns related to clinical trial design, patient recruitment and retention, site selection, medical data interpretation and evaluation of treatment efficacy, which are encountered during trial conduct.
Published: 2024-02-07
Pages: 86
USD 2900.00 (Single User License)